Ameritas Investment Partners, Inc. - KALA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 75 filers reported holding KALA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$5,000
+25.0%
3,4970.0%0.00%–
Q4 2021$4,000
-55.6%
3,4970.0%0.00%–
Q3 2021$9,000
-52.6%
3,4970.0%0.00%
-100.0%
Q2 2021$19,000
-20.8%
3,4970.0%0.00%0.0%
Q1 2021$24,0000.0%3,4970.0%0.00%0.0%
Q4 2020$24,000
-7.7%
3,4970.0%0.00%0.0%
Q3 2020$26,000
-29.7%
3,4970.0%0.00%
-50.0%
Q2 2020$37,000
+236.4%
3,497
+190.4%
0.00%
+100.0%
Q1 2020$11,000
+175.0%
1,2040.0%0.00%–
Q4 2019$4,000
-20.0%
1,2040.0%0.00%–
Q3 2019$5,000
-37.5%
1,2040.0%0.00%–
Q2 2019$8,000
-20.0%
1,2040.0%0.00%–
Q1 2019$10,000
+66.7%
1,2040.0%0.00%–
Q4 2018$6,000
-50.0%
1,2040.0%0.00%
-100.0%
Q3 2018$12,000
-29.4%
1,2040.0%0.00%0.0%
Q2 2018$17,000
-10.5%
1,2040.0%0.00%0.0%
Q1 2018$19,000
+46.2%
1,204
+73.2%
0.00%0.0%
Q4 2017$13,000–695–0.00%–
 Download
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,333,333$5,073,000100.00%
CAXTON CORP 1,483,343$5,644,0006.36%
Polaris Venture Management Co. V, L.L.C. 1,197,032$4,555,0002.59%
RA Capital Management 4,537,478$17,265,0001.03%
Orbimed Advisors 3,447,840$13,119,0000.25%
Matisse Capital 46,500$177,0000.22%
PURA VIDA INVESTMENTS, LLC 332,831$1,266,0000.22%
Sofinnova Investments, Inc. 478,206$1,819,0000.16%
HARBOURVEST PARTNERS LLC 99,186$377,0000.16%
ALGERT GLOBAL LLC 47,195$180,0000.07%
View complete list of KALA PHARMACEUTICALS INC shareholders